Page 26 - FIMM_Brochure_2022
P. 26
MNeatiwnoIrnktesrnational
Nordic EMBL Partnership for FIMM is the Finnish node of one of the first EMBL remote
Molecular Medicine partnerships, the Nordic EMBL Partnership for Molecular
Medicine initiated in 2008, and expanded in 2013. The
As a major strategic player in the European Partnership now consists of four Nordic research centres,
research community, the Nordic EMBL with more than 60 group and team leaders and over 600
Partnership leverages complementary researchers and staff.
research expertise, outstanding research
infrastructures and industry collaborations The Partnership combines and leverages the diverse, but
in its pursuit of a molecular understanding complementary, research and technology expertise of
of disease. the Nordic countries to take a leading role in addressing
some of the biggest challenges in biomedicine today. To
The European Molecular Biology Laboratory (EMBL) is an deliver on this vision, we facilitate scientific exchange and
intergovernmental organisation dedicated to molecular support in areas of common interest, especially where one
biology research established in 1974. It is Europe’s leading partner has a recognised expertise, which can be shared
life sciences laboratory and supported by the 27 member for the benefit of the other partners. And, we strive to re-
states. EMBL conducts world-class biological research, tain and attract the very best international research talent
provides advanced training for students and scientists, by providing an excellent and dynamic research environ-
and a wide range of state-of-the-art technologies. ment for young, talented researchers with the aim that
they will continue their scientific careers in one of
As defined by EMBL, EMBL institutional partnerships are the Nordic countries.
close cooperative affiliations between EMBL and external
institutions of comparable standard, vision and interna- Members:
tional orientation. Remote partnerships were inspired
by the desire of member states to make sure that EMBL’s l Institute for Molecular Medicine Finland (FIMM)
research strategy and operational model are implemented at the University of Helsinki (Finland)
on the national level.
l Laboratory for Molecular Infection Medicine Sweden (MIMS)
Nordic EMBL Partnership Meeting, Oslo 2018 at Umeå University (Sweden)
l Centre for Molecular Medicine Norway (NCMM)
at the University of Oslo (Norway)
l Danish Research Institute of Translational Neuroscience
(DANDRITE) at Aarhus University (Denmark)
26 | FIMM – Building a Bridge from Discovery to Medicine
